Clinical Severity and Serotonin Toxicity in Antidepressant Self-Poisoning: Implications for Clinical Risk Assessment
Psychiatry and Clinical Psychopharmacology · 12.08.2026 · 36 (4) · 430-440
DOI: 10.65801/pcp.3541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry and Clinical Psychopharmacology, online erschienen am 12.08.2026. Verfasst von Meltem Gürü und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Health Sciences University Etlik City Hospital, Ankara, Türkiye. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Antidepressant self-poisoning is a common form of intentional self-harm, and comparisons across antidepressant groups are complicated by differences in ingested dose and coexposures.
Methods
This retrospective cross-sectional study reviewed emergency department presentations coded with International Classification of Diseases, 10th Revision (ICD-10) X61/X64 between 01 January 2023 and 15 May 2025. Among 15,160 screened records, 168 patients with documented antidepressant ingestion with self-harm/suicidal intent were included. Antidepressant exposures were classified by group and standardized using defined daily dose (DDD). Clinical presentation, serotonin toxicity based on the Hunter Serotonin Toxicity Criteria, management, and short-term outcomes were evaluated. Multivariable logistic regression was used to adjust for log-transformed DDD.
Results
The median age was 27.0 years, and 66.7% of patients were female. Selective serotonin reuptake inhibitors (SSRIs) were the most frequently ingested antidepressants (79.8%). Symptomatic presentation occurred in 33.3% of patients and was more frequent in non-SSRI than in SSRI exposures 55.9% vs 27.6%; adjusted OR, 3.40; 95% CI, 1.55-7.43; P = .002). Serotonin toxicity was identified in 7.7% and was also more frequent in non-SSRI exposures (23.5% vs 3.7%; adjusted OR, 8.17; 95% CI, 2.45–27.26; P = .001). Serotonin toxicity was associated with intensive care unit (ICU) admission (53.8% vs 10.3%; P < .001).
Conclusion
Non-SSRI antidepressant exposures were associated with greater short-term clinical severity than SSRI exposures. Because non-SSRI subgroups were small and heterogeneous, class-specific findings should be interpreted as exploratory. The early clinical pattern of toxicity may inform shortterm risk assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Health Sciences University Etlik City Hospital, Ankara, Türkiye.
- Department of Emergency Medicine, Ankara Bilkent City Hospital, Ankara, Türkiye.
ORCID-Profile: Meltem Gürü, Merve Unutmaz
Zitieren
APA
Gürü, M., & Unutmaz, M. (2026). Clinical Severity and Serotonin Toxicity in Antidepressant Self-Poisoning: Implications for Clinical Risk Assessment. Psychiatry and Clinical Psychopharmacology, 36(4), 430-440. https://doi.org/10.65801/pcp.3541
Vancouver
Gürü M, Unutmaz M. Clinical Severity and Serotonin Toxicity in Antidepressant Self-Poisoning: Implications for Clinical Risk Assessment. Psychiatry and Clinical Psychopharmacology. 2026;36(4):430-440. doi:10.65801/pcp.3541
BibTeX
@article{Gr2026,
author = {Gürü, Meltem and Unutmaz, Merve},
title = {Clinical Severity and Serotonin Toxicity in Antidepressant Self-Poisoning: Implications for Clinical Risk Assessment},
journal = {Psychiatry and Clinical Psychopharmacology},
year = {2026},
volume = {36},
number = {4},
pages = {430--440},
doi = {10.65801/pcp.3541}
}
EUVIMED